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A Simulated Microgravity 
environment causes a Sustained 
Defect in epithelial Barrier function
Rocio Alvarez1,4, Cheryl A. Stork1,2, Anica Sayoc-Becerra1, Ronald R. Marchelletta2,5, 
G. Kim prisk2,3 & Declan F. Mccole  1*
Intestinal epithelial cell (IEC) junctions constitute a robust barrier to invasion by viruses, bacteria and 
exposure to ingested agents. Previous studies showed that microgravity compromises the human 
immune system and increases enteropathogen virulence. However, the effects of microgravity on 
epithelial barrier function are poorly understood. The aims of this study were to identify if simulated 
microgravity alters intestinal epithelial barrier function (permeability), and susceptibility to barrier-
disrupting agents. IECs (HT-29.cl19a) were cultured on microcarrier beads in simulated microgravity 
using a rotating wall vessel (RWV) for 18 days prior to seeding on semipermeable supports to measure 
ion flux (transepithelial electrical resistance (TER)) and FITC-dextran (FD4) permeability over 14 days. 
RWV cells showed delayed apical junction localization of the tight junction proteins, occludin and 
ZO-1. The alcohol metabolite, acetaldehyde, significantly decreased TER and reduced junctional ZO-1 
localization, while increasing FD4 permeability in RWV cells compared with static, motion and flask 
control cells. In conclusion, simulated microgravity induced an underlying and sustained susceptibility 
to epithelial barrier disruption upon removal from the microgravity environment. This has implications 
for gastrointestinal homeostasis of astronauts in space, as well as their capability to withstand the 
effects of agents that compromise intestinal epithelial barrier function following return to Earth.
A microgravity environment, such as that encountered in spaceflight, has been demonstrated to affect basic cel-
lular function in complex biological organisms and in cells. Genetic, biochemical and morphological parameters 
have all been shown to be modulated by a microgravity environment in multiple cell types1–6. A major technical 
resource in the study of the biological effects of reduced microgravity has been the development of the rotating 
wall vessel (RWV). The RWV is a rotating bioreactor that maintains cells in a controlled rotation environment 
where randomization of gravitational vectors creates a low shear simulated microgravity fluid environment. This 
system serves to model the impact(s) of microgravity or weightlessness on in vitro cultured cells. In addition, 
since the RWV environment is mixed by gentle rotation, lacks an air-fluid interface despite efficient oxygenation, 
and maintains laminar fluid flow, it avoids the large shear stress caused by turbulent flow7–12. Since the RWV 
minimizes the impact of gravitational force, it permits study of the effects of weight, or lack of weight in this case, 
on biological systems. Consequently, the environment could most accurately be referred to as “near weightless-
ness”13. One important clarification is that because microgravity simulation experiments can only change the 
influence of the Earth gravity vector and not its magnitude, true microgravity cannot be fully accomplished with 
a mechanical simulator14. Therefore, a ground-based simulator such as a RWV has the capacity to model the 
perception of low-shear microgravity by creating a functional weightlessness as perceived by the organism or cell 
being investigated11,13.
Previous studies investigating the response of epithelial cells to reduced or simulated microgravity identified 
that HT-29.cl19a colonic epithelial carcinoma cell line clones were capable of forming attachments to extracel-
lular matrices following culture in a RWV as efficiently as cultures at normal G15,16. This is important in that it 
suggests that reduced gravity does not affect the ability of intestinal epithelial cells (IEC) to attach to basement 
membrane proteins, a fundamental step in the formation of a monolayer. Elegant studies by Honer zu Bentrup et 
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al.17, and Drummond et al.18, confirmed that HT-29.cl19a and Caco-2 IECs form monolayers when cultured on 
microcarrier beads, form distinct tight junction and adherens junction complexes and exhibit different patterns 
of gene expression when cultured in 3-D structures vs. conventional 2-D culture in culture plates (non-polarized). 
Of the genes upregulated in 3-D cultures, many were associated with epithelial differentiation17,18. This aligns 
with earlier findings from studies in renal epithelial cells cultured in RWV or on the space shuttle, that showed 
dramatic changes in morphology that more resembled epithelial cells in vivo compared with 2-D culture, and in 
the expression of many gene groups including those associated with transcription factors, signaling proteins and 
cytoskeletal proteins6,19,20. Moreover, a clear morphological consequence of altered gravity was shown as cells cul-
tured in the RWV, and to a greater extent on the space shuttle, exhibited increased number and size of microvilli 
compared with control cells cultured on Earth at normal G. This is an intriguing observation given that epithelial 
cell culture on Earth is associated with reduced numbers of microvilli compared to epithelial cells in vivo15,19.
Another striking observation that was made in astronauts post-flight was that they exhibit immunosuppres-
sion of multiple immune cell subtypes21–27. In addition, the suppressive effects of space flight on immune function 
are compounded as a risk factor for long term habitation in space by evidence from Wilson et al.28, showing 
increased virulence of a foodborne bacterial pathogen, Salmonella typhimurium after time spent in space. This 
was complemented by ground-based studies demonstrating altered bacterial virulence or adherence by either 
bacterial or epithelial cell culture respectively in the simulated microgravity environment of the RWV17,18,29,30.
This prompted our interest in understanding how the barrier properties of the single layer of epithelial cells 
that line the gastrointestinal tract are affected by microgravity. The barrier function of the intestinal epithelium 
is critical for the maintenance of intestinal homeostasis and when disrupted, can lead to increased permeability 
to bacterial products, antigens and precipitate inappropriate inflammatory responses. This can greatly increase 
the risk of infections, and chronic inflammatory conditions including inflammatory bowel disease, celiac disease, 
Type 1 diabetes and liver disease31–34. Of significance is that these chronic conditions exhibit an increase in intesti-
nal permeability prior to the onset of inflammation as shown in animal models and patient studies35–37. Therefore, 
we set out to assess if exposure of intestinal epithelial cells (IEC) to a simulated microgravity environment resulted 
in a decrease in barrier function and/or increased susceptibility of the barrier following challenge with an agent 
capable of compromising the barrier. The permeability-inducing agent we chose to investigate was the alcohol 
metabolite, acetaldehyde. Alcohol increases gastrointestinal macromolecule permeability in normal subjects, in 
patients with alcoholic liver disease (ALD) and also in animal models38–41. Ingested alcohol undergoes a series 
of metabolic steps to facilitate its elimination with the generation of acetaldehyde representing the primary, and 
most toxic, ethanol metabolite. In the gastrointestinal tract, luminal acetaldehyde production can occur via the 
activity of cytochrome P450 2E1 or alcohol dehydrogenase from the mucosal epithelium or bacterial sources 
respectively42,43. Studies in rats demonstrated that chronic ethanol administration resulted in high concentrations 
of acetaldehyde in the colonic lumen. Of note, antibiotic treatment partially attenuated this increase, thus indi-
cating a detectable role for gut bacteria in acetaldehyde generation43. With respect to pathologic consequences of 
ethanol ingestion and metabolism, evidence from in vivo and in vitro studies indicated that acetaldehyde elevates 
intestinal and cultured IEC permeability to endotoxin or other permeability markers44–46. Epithelial barrier func-
tion is principally regulated by apical tight junctions47–49. Mechanistic studies have demonstrated that increases in 
paracellular permeability caused by ethanol or acetaldehyde exposure are associated with redistribution of tight 
junction proteins such as occludin and zona occludens-1 (ZO-1), from the intercellular junctions into intracellu-
lar compartments50–52. Colocalization of ZO-1, the first identified tight junction plaque protein, and occludin, the 
first identified tight junction transmembrane protein, at the tight junction is a strong indicator of barrier integrity, 
and reduction of this membrane colocalization is indicative of a compromised barrier53–55. ZO-1 is a scaffold 
protein that localizes to the apical tight junction where it maintains cell polarity and is essential to the formation 
of the tight junctional complex56–58. While ZO-1 knockout mice are embryonic lethal, the importance of ZO-1 
to barrier function was demonstrated by decreased transepithelial electrical resistance in siRNA-mediated ZO-1 
knockdown studies in epithelial cell lines59. Occludin is a member of the MARVEL (MAL and related proteins for 
vesicle trafficking and membrane link) domain–containing family of proteins involved in membrane apposition60. 
Occludin is a tetraspan transmembrane protein that primarily localizes to bicellular tight junctions in association 
with binding to ZO-161,62. While occludin’s importance to barrier function is somewhat controversial, it has been 
confirmed to contribute to tight junction stabilization and optimal barrier function by restricting macromolecule 
permeability and modification of claudin-2-mediated cation permeability61. It therefore appears to act primarily 
as a regulator of tight junctions rather than as an essential structural component58. However, conditions of cellular 
stress, such as inflammatory cytokine challenge, can induce internalization of ZO-1 and occludin and this action 
is associated with a compromised epithelial barrier63,64. Here, we investigated if simulated microgravity, generated 
by culturing IECs in the RWV, altered junction formation and functional barrier properties of polarized epithelial 
monolayers, and if subsequent exposure to acetaldehyde induced a differential effect on barrier integrity in cells 
exposed to simulated microgravity conditions. Moreover, our study is the first to investigate if functional changes 
to epithelial cell barrier properties were sustained over time following removal from the simulated microgravity 
environment.
Results
Growth of IECs on microcarrier beads. HT-29.cl19a cells were grown on beads for 18 days in a rotating 
wall vessel (RWV) as previously shown11,17,18. Under these conditions, HT-29.cl19a cells form a single layer of 
cells covering each bead as demonstrated successfully in prior studies17. In Fig. 1 we show (A) an uncovered 
microcarrier bead and (B) a bead around which HT-29.cl19a cells have formed a continuous layer. Figure 1C,D 
show an uncovered bead and a covered bead respectively that have been embedded in LR White, sectioned and 
stained with the vital dye, Toluidene Blue65. Figure 1 D shows uptake of Toluidene Blue by cells surrounding the 
bead indicating that the cells are viable. We also showed that these cells grow as a monolayer around the surface 
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of the bead. This was demonstrated by immunofluorescence staining of nuclei and the transmembrane tight 
junction protein occludin in whole mount imaging of beads and in cross-section (Fig. 1E–H). Furthermore, these 
monolayers are capable of forming tight junctions as shown by the apico-lateral membrane staining of occludin 
(Fig. 1I,J)17,51,66,67. The cytoskeletal protein, actin, that plays a critical role in maintaining the architecture of cell 
junctions, also localized intensely at the apicolateral membrane thus suggesting that polarization is not disrupted 
(Fig. 1K,L). These data show that HT-29.cl19a IECs are capable of attaching to and growing on microcarrier beads 
in a manner that facilitates formation of tight junctions.
RWV culture affects barrier formation. Having shown that we could culture IECs on microcarrier beads 
in the RWV and observe expression of tight junction proteins, we next wanted to perform functional measures 
of barrier integrity. In order to accomplish this however, we had to resort to growing cells on conventional inserts 
i.e. a 2–3D format having first exposed them to a simulated microgravity environment by culturing them on 
microcarrier beads (Fig. 2A). After culture in the RWV for 18 days, cells were removed from microcarrier beads 
by trypsinization, and seeded onto semi-permeable filter supports at a density of 5 × 105 cells per support. Two 
separate control cultures were also prepared. A ‘flask’ control was prepared by culturing cells in a T75 flask prior 
to seeding on filter supports while a ‘static’ control involved culturing cells on microcarrier beads in a culture dish 
as opposed to the RWV. This control was particularly important as it served as the substrate control for cells in 
the RWV cultured on the same type of bead. Cells were cultured on inserts up to 14 days and TER was monitored 
over time. No significant difference was observed in raw TER values over time between the different conditions 
(Fig. 2B). When the relative change in TER between cells cultured in the RWV and the respective controls was 
calculated, there was no consistent difference detected vs. cells from a flask not subjected to the simulated micro-
gravity environment (Fig. 2C). However, when cells from the RWV were compared with the appropriate substrate 
control – the static control – the simulated microgravity environment caused a slight but consistent drop in 
TER over the duration of the experiment (Fig. 2C). The most prominent change in %TER in RWV cells vs. static 
controls was observed on day 11(−6 ± 3% decrease vs. static; n = 4). This decrease did not reach statistical signif-
icance and was not due to differences in seeding density (data not shown). These data suggest that exposure to a 
Figure 1. HT-29.cl19a cells attach and form 3-D monolayers on individual microcarrier beads. HT-29.cl19a 
intestinal epithelial cells were cultured with microcarrier beads for 18 days under the conditions of simulated 
microgravity in a rotating wall vessel (RWV) at 16–17.8 rpm. (A,B) Samples were removed from the RWV for 
observation under an inverted light microscope (Panel A,: day 1, panel B, day 11) and embedded in LR White 
and stained with Toluidine Blue for EM imaging (Panels C,D, day 1, day 18). Panels A and C show a bead 
lacking cell attachment. By comparison, panels B and D show that cells attached and grew around individual 
beads. (D) Cells in panel D were able to take up the vital dye, Toluidene Blue, thus demonstrating viability of 
cells in situ on the microcarrier bead. Panels C,D shown in cross-section with the center of the hollow bead 
indicated by an asterisk. (E,F) whole cell-bead aggregates were stained for nuclei (DAPI) and the tight junction 
protein, occludin, showing an intact layer around the surface of the bead and tight junction formation. (G,H) 
Cross-section shows that cells grew as a unicellular layer around the outer surface of the bead. (I) Staining of 
cellular junction formation on cell-bead aggregates shows apico-lateral staining of (J) occludin and (K) actin 
with (I) nuclei stained by DAPI and (L) showing an overlay image of all three stains. Arrow indicates occludin 
staining at a cell-cell junction.
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simulated microgravity environment induces a subtle change in IEC barrier formation that is retained up to 14 
days following removal from the simulated microgravity environment.
Simulated microgravity alters tight junction protein localization not expression. To understand 
the molecular changes that might contribute to altered barrier function in cells subjected to simulated micro-
gravity, we investigated whether cells cultured in the RWV exhibited changes in expression or localization of 
the key tight junction proteins, occludin and ZO-1. Localization of occludin and ZO-1 was monitored from day 
9–14 post seeding on inserts after removal of cells from beads (RWV, static control) or flasks (flask control). Cells 
were stained in situ on inserts. On day 9, both ZO-1 and occludin localized to the cell membranes in flask control 
cells, and to a lesser extent in static control cells, as demonstrated by the sharp chicken-wire pattern of staining 
(Fig. 3A). However, in RWV-cultured cells, both tight junction proteins had a more diffuse sub-membranous 
localization. This did not appear to be due to a defect in actin localization or expression as actin showed a very 
clear pattern of staining in RWV-cultured cells similar to flask controls and superior to static controls. The same 
pattern of diffuse sub-membrane localization of ZO-1 and occludin was observed in RWV cells on day 11. 
However, by day 14 both ZO-1 and occludin had localized at cell membranes similar to flask and static control 
cultures. We quantified the staining intensity of each TJ protein over 6 intervals from day 2 to day 14 post-seeding 
(Fig. 3B,C). A significant decrease in ZO-1 was observed in RWV-treated cells only at day 9 and this subsequently 
reached equivalent expression with the flask control cells by day 11 (p < 0.05; n = 4; Fig. 3C). A decrease in ZO-1 
staining was also observed in the static condition at day 9 but this did not reach significance. While occludin 
levels were higher in RWV cells at day 2 compared with flask and static controls, they were decreased at day 11 
compared with flask controls but reached equivalent levels to both flask and static controls on day 14 (p < 0.05; 
n = 4; Fig. 3C). Overall, these data suggest that the altered TER in RWV cells is likely due to delayed membrane 
localization of ZO-1 and occludin rather than reduced expression. This may be due to possible effects on the 
trafficking of tight junction proteins to the apical membrane and delayed junction formation in IECs subjected 
to simulated microgravity.
Figure 2. Low shear simulated microgravity exposure affects epithelial barrier formation. A) Model of 
polarized intestinal epithelial monolayers cultured on a semi-permeable support. (B) TER values (days 2–14) 
of HT-29.cl19a cells grown on semi-permeable inserts following culture under normal cell culture conditions 
(flask control), cultured on microcarrier beads alone (static control), or cultured on microcarrier beads and 
exposed to simulated microgravity (RWV). No statistically significant underlying differences in overall TER 
raw values were observed between conditions. (C) Data are shown as the % change in TER of cells exposed to 
microgravity vs. static (black) or flask controls (white). No statistically significant difference was observed in % 
change between the different culture conditions, although the % change in TER of cells from RWV relative to 
the static control was consistently lower (n = 4).
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Simulated microgravity increases epithelial barrier susceptibility to challenge. Having shown that 
culturing IECs in the RWV led to a small drop in TER compared with static controls (c.f. Figure 2), we next inves-
tigated if RWV culture pre-disposed IECs to a greater drop in barrier function in response to an agent that com-
promises barrier integrity. Acetaldehyde is the major metabolite of alcohol and has been shown to directly reduce 
barrier function following in vitro administration to IEC cultures, as well as mediate the effects of ethanol adminis-
tered in vivo43,44,51. Acetaldehyde vapor was the preferred mode of administration as it delivers a consistent and titrat-
able dose of acetaldehyde to cells cultured in neighboring wells68. We treated cells at day 11 and day 14 post-RWV 
culture in order to assess whether barrier defects in response to challenge were apparent before and after appropriate 
localization of ZO-1 and occludin to cell membranes in RWV cultured cells (c.f. Figure 3). Exposure of cells on day 
11 post-seeding to 0.5% acetaldehyde vapor for 5 hrs led to a significant decrease in TER in RWV cultures compared 
with flask and control cells (p < 0.001; n = 7; Fig. 4A). No change in TER occurred in untreated cultures over the 5 hr 
incubation period. In parallel, a significant increase in permeability to 4kD FITC-dextran occurred in RWV cells 
exposed to acetaldehyde (p < 0.001; n = 7; Fig. 4B). When cells at day 14 post-seeding were exposed to acetaldehyde, 
similar defects in barrier function were observed as TER was significantly reduced (p < 0.001; n = 6; Fig. 4C) while 
permeability to FITC-dextran was significantly increased (p < 0.001; n = 7; Fig. 4D). These data indicate that cells 
cultured in the RWV exhibit a significantly greater susceptibility to an agent that compromises barrier function than 
control cultures even when tight junction proteins appear to have localized appropriately at the cell membrane (day 
14, c.f. Figure 3). Interestingly, FITC-dextran permeability in untreated RWV cells was elevated above the respective 
controls at day 11 but not day 14 and is thus consistent with data in Fig. 3 indicating maturation of tight junctions in 
cells cultured in the RWV and subsequently grown on inserts for 14 days.
Figure 3. Delayed tight junction formation in IECs exposed to simulated microgravity. HT-29.cl19a IECs 
were fixed with 4% paraformaldehyde, immunostained for ZO-1 (green) and occludin (red) and imaged by 
confocal microscopy. Actin was stained with Phalloidin. Arrows indicate the presence of apical tight junctions. 
Reduced levels of ZO-1 and occludin were observed in apical tight junctions on day 9 and 11 in IECs exposed 
to simulated microgravity. Levels appeared to recover by day 14 although substantial levels of ZO-1 appeared 
to be present in the cytoplasm and not at the tight junction. (B,C) Confocal imaging and quantification of total 
B) ZO-1 and (C) occludin levels was performed using a Zeiss Axioscope 2 upright microscope and Zeiss LSM 
5 Image Examiner software respectively. No consistent differences in protein levels were evident between the 
different conditions over the culture period on semi-permeable supports, although ZO-1 levels were lower in 
RWV and static controls vs. flask control at day 9, while occludin levels were reduced in the RWV condition at 
day 11 (*p < 0.05; n = 4).
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Random motion does not reproduce the effects of simulated microgravity on alcohol-induced 
barrier defects. While the static condition served as a valuable substrate control for cells bound to micro-
carrier beads, we next determined if physical motion could recapitulate the effects of simulated microgravity 
in promoting a sustained susceptibility to barrier defects. As a model of physical motion, we cultured cell-bead 
aggregates in a “Biowiggler” device that can physically thrust structures in solution in 3-dimensions, with 
reduced unidirectional shear, at adjustable speeds to accommodate cell growth and therefore increased mass of 
the cell-bead aggregate over time. The Biowiggler has been utilized with a number of different cell culture systems 
to model the impact of motion on biological properties. We initially performed careful optimization protocols 
to determine the appropriate duration, speed and vigor of movement in which cell-bead aggregates could be 
cultured to ensure complete cell coverage of beads and subsequent successful seeding onto transwells (data not 
shown). HT-29.cl19a IECs were cultured on microcarrier beads for 12 days in the Biowiggler with matching 
cell-bead aggregates cultured in the RWV until confluent cell-bead aggregates formed (Fig. 5A). Staining for 
actin indicated appropriate cell cytoskeletal architecture in cell-bead aggregates cultured in the Biowiggler and 
RWV environments (Fig. 5B). Cells were subsequently disassociated from the beads by gentle detachment using 
Accutase cell detachment solution and seeded at a density of 0.5 × 106 on 12 mm transwells. Cells were cultured 
for 11 days before exposure to acetaldehyde vapor as previously. Paired cultures were then treated with vehicle 
control or acetaldehyde vapor (0.5% for 5 hrs) and barrier properties were determined. TER was significantly 
reduced by acetaldehyde in cultures originating in the RWV compared with the control flask condition as previ-
ously (p < 0.05; n = 3; Fig. 5C). However, cells cultured in the Biowiggler showed no significant increase in sus-
ceptibility to acetaldehyde compared with control (Fig. 5C). Similarly, the acetaldehyde induction of permeability 
to FD4 was potentiated in cells previously cultured in the RWV compared with control (p < 0.05; n = 3), but cells 
cultured in the Biowiggler showed no significant increase in permeability relative to the flask control (Fig. 5D). 
These data indicate that the sustained increase in susceptibility to acetaldehyde challenge that occurs in cells cul-
tured in a simulated microgravity cannot be recapitulated by randomized motion.
Expression of epithelial tight junction proteins is unaltered by simulated microgravity with 
or without acetaldehyde challenge. Increased paracellular permeability to macromolecules such as 
FITC-dextran (FD4), following challenge of epithelial cells with barrier disrupting agents is often associated with 
reduced expression of tight junction proteins such as occludin and ZO-1. After being cultured in tissue culture 
flasks, the Biowiggler or the RWV, HT29 cells were subsequently seeded and grown on transwells as monolayers 
Figure 4. Simulated microgravity increases susceptibility of IECs to acetaldehyde-induced barrier dysfunction. 
(A) IECs grown on inserts for 11 days post-RWV culture exhibit a significant decrease in TER after 5hrs of 
acetaldehyde treatment (###p < 0.001 vs. RWV untreated) vs. static (***p < 0.001) and flask controls (***p < 0.001; 
n = 7). (B) IECs at 11-day post-RWV also showed an increase in FD4 permeability after acetaldehyde treatment 
vs. static and flask controls (n = 7). Similarly, panel C shows IECs at 14-day post-RWV exhibited a significant 
decrease in TER (*p < 0.05, n = 6) vs. untreated controls, and a non-significant decrease in TER vs. static and flask 
controls (n = 6). (D) IECs at 14-day post-RWV have increased permeability to FD4 in response to acetaldehyde 
treatment (###p < 0.001 vs. RWV untreated) vs. static and flask controls (***p < 0.001, n = 7).
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and subsequently subjected to 0.5% acetaldehyde vapor, as indicated. HT-29.cl19a monolayers were then lysed 
and processed for Western blotting. Compared to untreated HT-29.cl19a IECs previously cultured in flasks, cells 
grown in the Biowiggler appeared to have slightly less ZO-1 protein expression, however this was not signifi-
cant (Fig. 6A; n = 3–4). Exposure to acetaldehyde of cells cultured in the Biowiggler or RWV had no effect on 
ZO-1 expression (Fig. 6A). Moreover, RWV culture conditions did not affect occludin expression in either the 
untreated or acetaldehyde vapor challenged condition (Fig. 6B). In addition, occludin expression was not signif-
icantly altered in cells from flasks or the Biowiggler exposed to acetaldehyde vapor compared to their respective 
untreated controls. These data suggest that cells subjected to growth conditions in the Biowiggler or the RWV, 
with or without subsequent exposure to acetaldehyde vapor, do not display substantial changes in the overall 
protein expression of ZO-1 or occludin tight junction proteins.
Acetaldehyde alters TJ protein localization in epithelial cells exposed to simulated microgravity. 
Immunofluorescence staining for ZO-1 and occludin at day 11 showed similar findings to data in Fig. 3 where 
untreated RWV cells exhibited delayed localization of these proteins to the tight junctions compared with flask 
and static controls (Fig. 7A). All three conditions showed disrupted membrane localization of ZO-1 and occludin 
following 5 hr exposure to acetaldehyde vapor (Fig. 7B). Actin filaments were disrupted in untreated RWV cells 
on day 11, while acetaldehyde treatment disrupted the actin cytoskeletal in all three culture conditions. At day 14, 
when RWV cells showed normal tight junction localization of occludin, ZO-1 and an intact actin cytoskeleton 
in untreated conditions (Fig. 7C), RWV cells showed a greater mislocalization of ZO-1 away from the cell mem-
brane following exposure to acetaldehyde vapor than flask or static controls (Fig. 7D). RWV and flask control cells 
also exhibited greater disruption of actin staining than static controls following acetaldehyde exposure. Overall, 
these data indicate that exposure to a simulated microgravity environment increases susceptibility of epithelial 
cells to acetaldehyde-induced functional barrier defects and tight junction reorganization.
Figure 5. Susceptibility to acetaldehyde induction of barrier defects is specific to the simulated microgravity 
condition. (A) HT-29.cl19a IECs were cultured as microcarrier bead-cell aggregates under established RWV 
conditions or in a ‘Biowiggler’. Cell-bead aggregate formation was sampled at day 12 and visualized under 
phase-contrast microscopy. (B) Immunofluorescence imaging shows bead coverage by IECs and formation 
of cell junctions as shown by actin staining (red). Nuclei were stained with DAPI (blue). (C) Cells were 
removed from beads or a control flask and cultured on semi-permeable supports (transwells) for 11 days. 
TER was recorded immediately prior to exposure of cells from each condition to acetaldehyde vapor (5hrs), 
and the change in TER caused by acetaldehyde was calculated and expressed as the % change in TER from t0 
to t5hr. Cells originally cultured in the RWV, but not the Biowiggler, showed a significantly greater decrease 
in TER from control flask conditions (*p < 0.05 vs. Flask + acetaldehyde condition; n = 3). (D) After 5 hrs 
of acetaldehyde vapor exposure, permeability to FD4 (over 1 hr) was measured and found to be significantly 
elevated in cells from the RWV, but not the Biowiggler compared with control cells. Data are expressed as fold 
change in FD4 permeability (*p < 0.05 vs. Flask + acetaldehyde condition; n = 3).
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Discussion
Existing data from space flight studies indicate that a microgravity environment can have profound effects on 
human physiology and lead to clinical symptoms and illnesses including gastroenteritis69. Moreover, animal stud-
ies in spaceflight identified morphological changes in the intestine that indicated reduced jejunal villus length 
Figure 6. Tight junction protein expression levels are not reduced by simulated microgravity conditions. 
HT-29.cl19a IECs cultured in tissue culture flasks (‘Flask’), the Biowiggler or the rotating wall vessel (RWV), 
were grown on transwells as monolayers and subsequently subjected to 0.5% acetaldehyde vapor for 5 hours. 
IEC monolayers were then lysed, processed for Western blotting and probed for the proteins indicated. (A) 
Representative blots probed for ZO-1, occludin and β-actin. (B) Quantification of densitometric analysis 
from Western blot experiments performed in duplicate (n  =  3–4 independent experiments). Non-contiguous 
sections of the same blot are indicated by a black line.
Figure 7. Simulated microgravity potentiates acetaldehyde-induced decrease in epithelial ZO-1. HT-29.cl19a 
IECs were fixed with 4% paraformaldehyde, immunostained for ZO-1 (green) and occludin (red) and imaged 
by Zeiss LSM 510. Actin was stained with phalloidin. Nuclear staining was performed using Hoechst 33258. 
Arrows indicate the position of apical tight junctions. (A) Reduced levels of ZO-1 were observed in apical tight 
junctions of IECs at 11 days post-RWV vs. static and flask control cells. (B) A greater reduction in junctional 
ZO-1 was observed in IECs at day 11 post-RWV following 5 hr acetaldehyde treatment versus the reduction 
seen in both static and flask controls. (C) Unchallenged IECs at day 14 post-RWV show ZO-I and occludin 
localization to membrane junctions similar to flask and static control conditions. (D) Acetaldehyde challenge (5 
hrs) disrupted junctions in all conditions but caused greater disruption of ZO-1 and occludin staining in the day 
14 post-RWV condition (n = 3).
9Scientific RepoRtS |         (2019) 9:17531  | https://doi.org/10.1038/s41598-019-53862-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
in rats. However, this was not attributed to defects in epithelial proliferation or migration but rather to changes 
in the cytoskeleton core of the intestinal villi presumably causing villus contraction70. To better understand the 
effects of microgravity on the functional behavior of the epithelial cells that line the intestinal tract, we exam-
ined the impact of simulated microgravity on intestinal epithelial cells cultured in a rotating wall vessel. The 
RWV generates a low shear simulated microgravity environment that enables epithelial cells to form 3-D cel-
lular aggregates with greater in vivo-like characteristics, including tight junctions and extracellular processes 
such as microvilli, than conventional 2-D culture where cells are grown as flat, two-dimensional monolayers 
on impermeable surfaces10,12,17,71. This device has also been utilized for the purposes of creating cell cultures for 
tissue engineering, the study of host-pathogen interactions and drug discovery10,12,72. It is important to note that 
whereas most studies analyzing 3-D epithelial cultures have used cells grown on a flat impermeable surface as a 
2-D control (flask condition in our studies), we removed cells from beads (RWV, static, Biowiggler conditions) 
and subsequently cultured them in a polarized manner on semi-permeable filters (transwells) in order to perform 
functional measurements of tight junction integrity. Therefore, these cells were grown in a more advanced system 
than 2-D as they are capable of correct spatial organization of apical vs. basolateral proteins and formation of tight 
junctions as determined functionally by measurement of TER, and visually by immunofluorescence staining. 
This necessary technical approach to facilitate functional and quantifiable measurement of barrier properties, 
also enabled us to determine if effects of the simulated microgravity environment in the RWV were retained by 
cells following removal from that environment. We demonstrated that following culture for 18 days in the RWV 
and subsequent seeding onto semi-permeable supports, that intestinal epithelial cells show delayed formation of 
tight junctions, as determined by membrane localization of occludin and ZO-1, as well as a minor reduction in 
barrier function. ZO-1, is a primarily apicolateral localizing protein that is critical for the formation of cell-cell 
junctions, although in undifferentiated cells, ZO-1 is found in other subcellular sites including the nucleus73,74. In 
our studies, ZO-1 staining in HT-29.cl19a monolayers generated from RWV-cultured cells showed a primarily 
cytoplasmic and perinuclear localization thus resembling ZO-1 distribution patterns in undifferentiated cells. Not 
until day 14 did the RWV cells display evidence of ZO-1 staining at lateral cell borders, indicative of differentiated 
cells. Occludin staining also exhibited delayed lateral membrane localization. This was in contrast to flask and 
static controls where occludin and ZO-1 had localized to the membranes as early as day 9. The delay in TJ protein 
localization may be due to a specific defect in trafficking of occludin and ZO-1 or possibly to an overall delay in 
differentiation of IEC that has been identified previously in a modeled microgravity environment15. In addition, 
the observed alterations in actin localization may contribute to a defect or delay in appropriate adherens junction 
protein localization, an event that precedes tight junction formation48,75. Indeed, the cytoskeleton has been pro-
posed as a gravity sensor in mammalian cells that lack a specialized organelle, such as a statolith in plants, while 
actin is capable of acting as a mechanosensor and disruption of actin filaments has been observed in a number of 
cell types subjected to spaceflight microgravity or simulated microgravity76–79.
The significance of our data lies in the novel finding that the low shear simulated microgravity environment of 
the RWV imprints an altered pattern of tight junction assembly that is retained up to 14 days after removal from 
the RWV. Although the magnitude of the decrease in TER of RWV cells compared with static controls is modest, 
it is consistent with observations that although various aspects of gastrointestinal function such as transit time, 
mucus secretion and nutrient uptake are compromised in astronauts and rodents after time spent in spaceflight, in 
general they do not suffer from severe GI distress80–84. However, the presence of a modest underlying barrier defect 
may predispose to a more deleterious response to agents that can enhance barrier defects. This principle of an 
underlying barrier defect that is not fully manifest until exposed to challenge, underpins much research into the eti-
opathogenesis of a number of chronic inflammatory conditions that feature increased intestinal permeability prior 
to onset of inflammation. These conditions include Crohn’s disease, ulcerative colitis, celiac disease and Type 1 
diabetes32. With this in mind, we investigated whether cells previously cultured in the RWV exhibited an increased 
response to an agent known to compromise barrier function, the alcohol metabolite, acetaldehyde. We tested cells 
grown on permeable supports at day 11 and day 14 after removal from the RWV. The significance of these time 
points is that evidence of tight junction assembly, as determined by tight junction protein localization, was not pres-
ent at day 11 but was detectable by day 14. At day 11, we observed a clear increase in susceptibility to the effects of 
acetaldehyde on both TER and permeability to 4kD FITC-dextran. This was consistent with the lack of tight junc-
tion protein localization at day 11. The most striking observation was that even at day 14 when ZO-1 and occludin 
were localized at lateral membranes, that a significant decrease in TER and increase in FITC-dextran permeability 
was clearly apparent. These data indicate that in spite of appropriate TJ protein localization, that a functional barrier 
defect was evident following challenge with an agent that compromises epithelial permeability. We were also able to 
generate data indicating that the sustained susceptibility to a barrier defect (induced by acetaldehyde challenge) was 
not due to randomized motion but was a specific attribute imparted by the simulated microgravity environment of 
the RWV. Western blot studies did not show any significant change in expression of total cellular occludin or ZO-1 
in unchallenged or acetaldehyde challenged 11-day old epithelial monolayers from control or RWV-cultured cells. 
When coupled with the immunofluorescence imaging data, this suggests that the functional barrier defects arising 
from RWV culture are likely mediated by changes in tight junction protein localization, and possibly signaling 
regulation, rather than alterations in total expression levels of individual junction proteins.
Our observations are further supported by a recent in vivo study using the ground-based hindlimb unloading 
model of microgravity simulation in mice. This identified changes in gut microbiome composition and increased 
susceptibility to the dextran sulfate sodium model of chemical colitis in mice subjected to hindlimb unloading85. 
The same study showed no effect of hindlimb unloading by itself on intestinal permeability as measured by in 
vivo FITC-dextran permeability. This is consistent with our findings that IECs cultured in the RWV simulated 
microgravity environment had no significant change in permeability until faced with experimental challenge. 
Moreover, while numerous studies have identified both positive and negative roles for the gut microbiome in 
modulating intestinal epithelial barrier function86,87, it is worth noting that the changes in composition and 
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structure of the intestinal microbial community observed after 4 weeks of hindlimb unloading by Shi et al.85 
were by themselves insufficient to provoke an increase in intestinal permeability. While the mice subjected to 
hindlimb unloading were subsequently more susceptible to challenge, the nature of the experimental challenge 
in this study did not selectively modify tight junction function as DSS acts by essentially destroying the epithelial 
monolayer thus obliterating tight junctions, whereas in our studies acetaldehyde vapor challenge of IECs does 
not cause chemical stripping of the epithelial lining but rather induces modulation of tight junction protein local-
ization while keeping the monolayer intact51,52,88. This was confirmed in our studies by a reduction in, but not a 
catastrophic loss of, TER in IEC monolayers exposed to acetaldehyde.
With respect to the mechanism(s) of increased susceptibility to acetaldehyde-induced barrier disruption, 
Sheth et al.52 showed that acetaldehyde destabilizes the interaction of junctional proteins with the actin cytoskel-
eton, and this contributes to mislocalization of the tight junction proteins occludin and ZO-1. The molecular 
changes observed in our study are consistent with our understanding of the effects of acetaldehyde on tight junc-
tions. The mechanisms involved in mediating this effect of simulated microgravity on barrier function and the 
increased susceptibility to alcohol metabolite challenge remain to be determined. They may involve epigenetic 
modulation of genes coding for proteins involved in junction assembly and protein trafficking, as suggested by 
the delayed junction localization of ZO-1 and occludin observed in cells cultured in microgravity conditions (c.f. 
Figure 3). These are attractive avenues for follow-up studies.
Of relevance to human health on Earth, adaptation to spaceflight shares many similarities with the effects 
of aging with respect to their impact on human physiology. Both of these factors exert effects at a cellular and 
molecular level that impact and promote a decline of multiple physiological systems in the body89,90. Pre- and 
post-flight testing has identified many physiological alterations that also occur in aging. These include bone 
density loss, muscle atrophy, negative calcium balance, cardiovascular changes, metabolic & endocrine effects, 
immune suppression and decreased gastrointestinal function84,91,92. One important difference between the effects 
of spaceflight and aging is that the effects of spaceflight are largely recoverable upon return to Earth, although 
flight durations have been quite short with the longest sustained period that any human has spent in space being 
14 months90. Of note, studies of digestive dysfunction in rats during spaceflight identified that altered hepatic 
and xenobiotic enzyme expression persisted upon return to Earth even after other digestive parameters had 
alleviated84. Nevertheless, spaceflight and approaches that try to recreate the conditions of spaceflight including 
head-down bed rest in the case of humans, or devices that simulate microgravity such as the rotating wall vessel 
in the case of cell cultures, have been used as model systems to study the effects of aging on various physiolog-
ical parameters and cell types8,16,93,94. A number of studies have identified increased intestinal permeability to 
macromolecules such as mannitol, and in particular, significantly elevated permeability in aged rodent intestine 
following challenge with agents that increase permeability such as phorbol ester50,95,96. Studies of human intestinal 
permeability in younger vs. elderly adult humans have centered on double sugar and lactulose:mannitol ratios, 
but while these studies did not show a clear difference between younger vs. older adults, interpretation of these 
data is complicated by an expected decrease in renal saccharide clearance with age, as well as a small sample 
size97,98. A study investigating the effects of aging on intestinal permeability in non-human primates identified 
an increase in macromolecule permeability to horseradish peroxidase and a decrease in the electrical integrity 
of aging intestine as assessed by potential difference (PD) measurements. Furthermore, these changes were also 
associated with decreased occludin and ZO-1 levels in colonic mucosal tissue99. Overall, our data share consist-
encies with animal studies identifying an increase in intestinal permeability associated with aging, albeit with a 
requirement for an experimental challenge to fully identify the nature of the barrier defect. Thus, the low-shear 
simulated microgravity environment generated by the RWV may also serve as a valuable model system to investi-
gate the effects of aging on epithelial barrier function as well as other properties of epithelial cells.
The data generated using the RWV system are intriguing and although further studies into the mechanism(s) 
responsible for the observed barrier defect in cells exposed to simulated microgravity are needed, we can spec-
ulate on the implications of these findings. The capacity of the RWV system to induce an underlying barrier 
defect in cells that have appropriate tight junction localization may serve as a very useful experimental model to 
study the pathogenesis of disease conditions associated with underlying barrier defects prior to disease activation, 
such as inflammatory bowel disease, or patients with increased sensitivity to barrier-disrupting agents such as 
alcohol. With respect to the potential impact of a microgravity environment on the gastrointestinal tract, these 
data suggest that intestinal epithelial cells develop a minor barrier defect possibly without significant pathologic 
manifestations until such time as they are exposed to an agent, either chemical or biological, that can compromise 
barrier function. This could result in a greatly exaggerated barrier defect that may have dramatic consequences 
for epithelial integrity and intestinal homeostasis. Specifically, given previous evidence of immunosuppression 
and increased virulence of pathogenic bacteria in conditions of microgravity, an underlying defect in the intes-
tinal epithelial barrier could greatly expedite bacterial colonization of the host, or effects of bacterial products, 
and give rise to a more rapid and severe infection. This may have particular relevance to long-term space travel 
and colonization where exposure to a food-borne pathogen may result in a more severe pathology than on Earth.
Materials and Methods
Microcarrier preparation. Cytodex-3 microcarrier beads (collagen and dextran coated, average 175 μm in 
size) were purchased from GE Healthcare (Piscataway, NJ) and prepared based on the manufacturer’s protocol. 
Beads were rehydrated in Ca2+ and Mg2+ free phosphate buffered saline (PBS)(50–100 ml/g) for 3 h at room 
temperature. Beads were sterilized by removal of the supernatant and 70% ethanol (70–100 ml/g) was added. 
Beads were washed twice in this manner and incubated in 70% ethanol solution overnight. Prior to use, beads 
were washed three times in PBS (50 ml/g) and once with culture medium (50 ml/g) before use. Corning enhanced 
attachment microcarrier beads, (cat#3779, Corning Inc., Corning, NY) were reconstituted in sterile, molecular 
grade water at a concentration of 200 mg/ml.
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Cell culture in the rotating wall vessel system. The development of 3-D cell culture model was per-
formed as previously described17,71,100. HT-29.cl19a cells were initially grown as monolayers with fresh McCoy’s 
5A media with L-glutamine (Mediatech, Manassas, VA) supplemented with 10% fetal calf serum (Hyclone, 
Waltham, MA; catalog # SH3007303), Penicillin (500 I.U.) and Streptomycin (10,000 ug/ml) (Mediatech) culture 
medium in T-75 cell culture flasks (Corning, Inc. Corning, NY) at 37 °C in a 5% CO2 environment in preparation 
for seeding into the rotating wall vessel (STLV, Synthecon, Inc, Houston, TX). Cells were cultured until approx-
imately 70–90% confluent. HT-29.cl19a monolayers were washed once with 0.25% Trypsin-ethylenediamine 
tetraacetic acid (Gibco, Carlsbad, CA), removed from flasks by treatment with 0.25% Trypsin-EDTA for 15 min-
utes at 37 °C and resuspended in fresh culture medium, supplemented with FBS (5%) and L-glutamine (2.5 mM), 
at a density of 2–2.2 × 105 cells/ml. Cells were assayed for viability by trypan blue exclusion. Cells were introduced 
to the RWV containing 5 ml/mg of Cytodex-3 microcarrier beads, or 250 mg of Corning microcarrier beads, 
resulting in a ratio of approximately 10 cells/bead. Cells were cultured in the RWV at a rotation speed adjusted to 
maintain beads and cells in suspension (16.8–17.8 rpm). HT-29.cl19a cells cultured with beads in a petri-dish in 
the absence of rotation exposure served as a substrate (Static) control. Fresh medium was replenished by 80–90% 
of the total volume after 3 days initially and every 24–48 h thereafter.
Cell culture in the random motion incubator (Biowiggler). The BiowigglerTM is a PC programmable 
eight-position stirrer that simplifies cell culture applications (Global Cell Solutions, Charlottesville, VA). Each of 
eight magnetic drive positions can be independently programmed to stir intermittently, continuously or “wiggle” 
in a reversing two-way motion. Proprietary LeviTubes (50 mL volume) were preconditioned for 24 hrs prior to 
cell seeding by adding warm PBS (1×) and placed in the Biowiggler to rotate bidirectionally at 40 rpm inside the 
CO2 incubator. Phosphate buffer was replaced by 25 mL of pre-warmed McCoys 5A media enriched with 10% 
FBS. To the LeviTubes and in sequence, 100 mg of reconstituted Corning enhanced attachment microcarrier 
beads (Corning, cat#3779; Corning Inc., Corning, NY) were added, followed by 5 × 106 HT-29.cl19a cells to a 
final volume of 40 mL. LeviTubes were placed in the CO2 incubator without shaking to allow the cells to attach to 
the carrier beads for 5 minutes. For the first 24 hours, LeviTubes were rotated bidirectionally at 40 rpm followed 
by a 5-minute static rest period. This combined period allowed rounded cells make contact with carrier beads 
(adsorption), followed by flattening of cells on the side of contact (attachment) to promote cell attachment to the 
microcarriers. Thereafter, cell aggregates continued to grow and proliferate by continued bidirectional rotation 
at 40 rpm. Media and cell cultures (50 μl aliquots) were monitored every 2 days. Media was changed every day.
Harvesting cells from microcarrier beads. Cells were harvested 18 days after initial seeding in the RWV 
or in respective control environments (Biowiggler; culture flask). Cells cultured with beads were removed from 
the RWV or petri-dish, allowed to settle, and incubated with Ca2+ and Mg2+ PBS containing 0.02% EDTA (w/v) 
(50–100 ml/g beads, pH7.6) for 5 minutes at 37 °C. The PBS-EDTA was removed and the beads were incubated 
with Accutase cell detachment solution (CorningTM cat 25058CI, Corning, NY) at 37 °C with occasional agitation 
for 15 minutes. After 15 minutes, 30 ml culture medium was added and detached cells separated from beads by 
filtration through a 100μm nylon filter (Millipore, Bellerica, MA). Detached HT-29.cl19a cells were re-suspended 
at a density of 2.5 × 105 cells/ml and seeded onto 12 mm semi-permeable polycarbonate inserts (Millipore) in 
24-well plates for 9,11 or 14 days for functional measurements of barrier integrity and to assess junction assembly.
Cell culture conditions for barrier function assays. Four cell culture growth conditions were used for 
seeding and growth of epithelial monolayers on transwells for the measurement of barrier properties:
Flask control. Monolayer controls for HT-29.cl19a were grown in T-75 flasks for 10–18 days prior to seeding on 
transwell inserts.
RWV. As described in detail above, HT-29.cl19a cells were cultured in the RWV at a density of 2.0–2.2 × 105 
cells/ml with microcarrier beads in a 10:1 ratio (cells:beads) at a rotation speed adjusted to maintain beads and 
cells in suspension (16.8–17.8 rpm) for 18 days.
Static control. HT-29.cl19a cells cultured at a density of 2.0–2.2 × 105 cells/ml with microcarrier beads in a 10:1 
ratio (cells:beads) in a petri-dish in the absence of rotation exposure. Media changes were performed to coincide 
with those of the RWV. This condition served as a microcarrier bead substrate control without the effects of the 
RWV (Static) control.
Biowiggler. As described in detail above, 5 × 106 HT-29.cl19a cells in cell culture media were added to 
custom-specific Levi tubes for pre-attachment prior to defined adsorption and attachment to microcarrier bead 
phases. Cell aggregates continued to grow and proliferate by continued bidirectional rotation at 40 rpm. Media 
and cell cultures were monitored every two days up to 18 days.
Acetaldehyde treatment studies. Acetaldehyde (200–400 μM)(Sigma Chemical Co, St. Louis, MO), 
treatment was performed as previously described51,68. After 11 or 14 days of culture post- seeding on transmem-
brane inserts, HT29Cl.19a cells were preincubated with PBS containing 1.33 mM CaCl2 and 1 mM MgCl2 for 
1 h. Cells were then exposed to 0.5% vapor-phase acetaldehyde in adjacent wells in a sealed 24-well culture plate 
for 5 h51. Cyanamide (10–50 μM) was added apically to inserts at the start of treatment to inhibit aldehyde dehy-
drogenase51. Addition of 0.5% vapor-phase acetaldehyde in the adjacent wells results in an approximate 400 μM 
acetaldehyde concentration in the buffer incubating the cell monolayers51.
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Transepithelial permeability studies. For permeability studies, HT-29.cl19a cells grown on 
semi-permeable membranes for 11 and 14 days were incubated with 1 mg/ml FITC-dextran in the apical well. At 
the end of acetaldehyde treatment, 100ul of media from the basolateral well was removed and fluorescence was 
measured with a microplate reader (SpectraMax M2, Molecular Devices). Transepithelial permeability was meas-
ured as 4-kilodalton fluorescein isothiocyanate-dextran (FITC-dextran; FD4) (Sigma Chemical Co, St. Louis, 
MO) flux across IEC monolayers.
Transepithelial electrical resistance. After 18 days of culture in the presence or absence of simulated 
microgravity, HT29.cl19a cells were seeded onto 12 mm semi-permeable inserts and cultured for 11 or 14 days. 
The transepithelial electrical resistance (TER) across HT-29.cl19a monolayers was assessed before and after treat-
ment using a voltohmeter (WPI, Sarasota, FL) and electrodes (WPI). To normalize the variation in TER, data 
were expressed as percentage of pre-treatment TER values.
Immunofluorescence microscopy. 2.5 × 105 HT-29.cl19a cells were seeded onto 12 mm Millicell-HA 
filters for 11 and 14 days prior to acetaldehyde treatment. After treatment, monolayers were fixed with 4% par-
aformaldehyde in PBS for 10 minutes at room temperature, permeabilized with 0.1% Triton-X 100 in PBS for 
10 minutes, and quenched with 50 mM ammonium chloride for 5 minutes. Between steps, cells were washed 
(x3) with PBS. Blocking was performed with 1% bovine serum albumin in PBS at 4 °C overnight. Cells were 
incubated with primary antibodies overnight at 4 °C in a humidified chamber. After PBS washing (x3), second-
ary antibodies: Alexa-488 conjugated goat anti-mouse (excitation/emission maxima at 495/519 nm; Molecular 
Probes, Eugene, OR), Alexa-568 conjugated goat anti-rabbit (excitation/emission maxima at 578/603;Molecular 
Probes, Eugene, OR) were added at a 1:100 dilution, and Alexa-647 Phalloidin (excitation/emission maxima at 
650/668 nm; Molecular Probes, Eugene, OR) was added at 1:25 dilution, in 1% BSA in PBS for 1 hour at 37 °C. 
After washing (three times with PBS), cells were incubated with Hoechst 33258 (excitation/emission maxima at 
352/461 nm; Molecular Probes) in PBS (1:100) for 5 min at 37 °C. The final washing stage consisted of 3 washes 
with PBS. Then the cells on the filter membrane were transferred onto glass slides and mounted in ProLong Gold 
Antifade Reagent (Molecular Probes). Confocal microscopy was performed using a Zeiss LSM 510 laser-scanning 
confocal system on a Zeiss Axioscope 2 upright microscope (Zeiss, Jena, Germany). Quantification of confocal 
images was performed using ImageJ. Briefly, the multicolor confocal image was separated into its composite 
colors using the Zeiss LSM 5 image examiner software. The resulting single-color field was exported into ImageJ 
and mean fluorescence intensity (MFI) was calculated using the Analyze-Measure function. MFI was measured 
and averaged from 5 fields/replicate from 3–4 independent experiments.
Microcarrier bead-cell aggregates were fixed in 4% buffered PFA, washed in PBS (Mg2+/Ca2+) and embed-
ded in O.C.T. (VWR). 5–8 μm sections were mounted on microscope slides, washed with PBS (Mg2+/Ca2+), 
permeabilized with 0.3% Triton in PBS for 30 minutes and consecutively blocked using 10% normal donkey 
serum in PBS-T (0.02%). Cells were stained using occludin primary antibody (Life Technologies) and after PBS 
wash, incubated with Alexa-488 conjugated anti-rabbit secondary antibody and Alexa-647 Phalloidin (Jackson 
ImmunoResearch Labs, West Grove, PA.) Cells were mounted using ProLong® Gold Antifade Reagent with 
DAPI (Life Technologies, Carlsbad, CA). Bead-cell aggregates were visualized under phase-contrast microscopy 
(EVOS microscope; AMG/Thermofisher, Waltham, MA). Immunofluorescence staining of bead-cell aggregates 
were imaged using a Leica DM5500 fluorescent microscope (Leica Microsystems, Inc., Buffalo Grove, IL). Image 
panels were assembled into complete figures in Adobe Photoshop (San Jose, CA).
Western blotting. After acetaldehyde treatment, cells from inserts containing HT-29.cl19a monolayers were 
suspended in ice-cold lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 20 µM NaF, 
1 mM EDTA, 1 µg/ml antipain, 1 µg/ml pepstatin, 1 µg/ml leupeptin, 1 mM NaVO3, 100 µg/ml phenylmethylsul-
fonyl fluoride). Cells were mechanically detached followed by centrifugation at 10,000 rpm for 10 minutes. Cell 
lysate supernatants were assayed for protein content using a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA). 
Equal concentrations of proteins lysates were resuspended in loading buffer (60 mM Tris-Cl pH 6.8, 2% SDS, 5% 
β-mercaptoethanol, 0.01% bromophenol blue, 10% glycerol) and incubated at 95 oC for 10 minutes. Proteins were 
separated by SDS-PAGE and transferred onto polyvinylidene fluoride membranes (Millipore). Membranes were 
blocked with nonfat milk in TBS-T (Tris-buffered saline with 0.1% Tween-20) for 1 h at room temperature prior 
to addition of primary antibody; ZO-1 (1:1000 dilution, #61-7300, ThermoFisher Scientific, Waltham, MA), or 
occludin (1:1000 dilution, #71-1500, Invitrogen, Carlsbad, CA), in 1% nonfat milk in TBST. Membranes were 
incubated overnight at 4 oC101. Membranes were washed 5x for 5 min per wash with TBS-T, then incubated with 
peroxidase-conjugated secondary antibodies (goat anti-mouse (#115-036-062) or goat anti-rabbit (#111-036-
045); Jackson Immunoresearch Laboratories, Inc. West Grove, PA) diluted at 1:5000 in 1% nonfat milk in TBST 
for 1 h at room temperature. Immunoreactive proteins were detected using SuperSignal West Pico chemilumi-
nescence detection kit (Thermo Scientific, Rockford, IL). Densitometric analysis of Western blots was performed 
using ImageJ software (National Institutes of Health).
Statistical analysis. Data are presented as ± SEM for a series of n experiments. Data are presented as per-
centage of respective controls, arbitrary units, or fluorescence units. Statistical analysis was performed by analysis 
of variance (ANOVA) and Bonferroni post-test using Graphpad Prism Software (GraphPad Software, La Jolla, 
CA). P values ≤ 0.05 were considered significant.
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